Home   |   About Us   |   Publications   |   Links   |   News   |   Members   |   Contact Us
 
 
Nutrigenomics New Zealand
 
 
  You Are Here:   Home / our publications /
 
   

Our nutrigenomics publications

2011

  1. Armstrong, K. M., E. N. Bermingham, et al. (2011). "Global DNA methylation measurement by HPLC using low amounts of DNA." Biotechnology Journal 6: 113-117.
  2. Barnett MPG & Fraser AG (2011). Animal Models of Colitis: Lessons Learned, and Their Relevance to the Clinic. In: Ulcerative Colitis - Treatments, Special Populations and the Future, Mortimer O'Connor (Ed.), ISBN: 978-953-307-739-0, InTech,  Available from: http://www.intechopen.com/articles/show/title/animal-models-of-colitis-lessons-learned-and-their-relevance-to-the-clinic
  3. Berger N, Bermingham EN, McNabb WC, Cooney JM & Roy NC (2011). Inflammatory Bowel Disease in "Inflammatory Diseases/Book 3", ISBN 979-953-307-659-0 (Accepted 27 July 2011).
  4. Edmunds SJ; Nicole C Roy, Donald R Love, William Laing (2011) Kiwifruit extracts inhibit cytokine production by lipopolysaccharide-activated macrophages and intestinal epithelial cells isolated from IL10 gene deficient mice. Cellular Immunology 270:70-9
  5. Edmunds SJ,  Nicole C Roy, Marcus Davey, Janine M Cooney, Matthew PG Barnett, Shuotun Zhu, Zaneta Park, Donald R Love, William A Laing. (2011) Effects Of Kiwifruit Extracts On Colonic Gene And Protein Expression Levels In Interleukin 10 Gene-Deficient Mice. Accepted British Journal of Nutrition
  6. Fenech M, El-Sohemy A, Cahill L, Ferguson LR, French T-AC, Tai ES, Milner J, Koh W-P, Xie L, Zucker M, Buckley M, Cosgrove L, Lockett T, Fung KYC and Head R (2011) Nutrigenetics and Nutrigenomics: Viewpoints on the Current Status and Applications in Nutrition Research and Practice. Journal of Nutrigenetics and Nutrigenomics 4:69-89.
  7. Gladine C, Roy NC, Laillet B, Rigaudière JP, Jouve C, Joly C, Park ZA, Morio-Lindore B, McNabb WC, Chardigny JM & Comte B (2011). Increasing intake of long chain omega 3 PUFA enhances lipoperoxidation and modulates hepatic gene expression in a dose-dependent manner. British Journal of Nutrition 14: 1-20.
  8. Huebner C, Ding Y, Petermann I, Knapp C and Ferguson LR (2011) The Probiotic Escherichia coli Nissle 1917 Reduces Pathogen Invasion and Modulates Cytokine Expression in Caco-2 Cells Infected with Crohn's Disease-Associated E. coli LF82. Appl Environ Microbiol 77: 2541-2544.
  9. Lin, H.-M., S. J. Edmunds, et al. (2011). "Metabolomic analysis reveals differences in urinary excretion of kiwifruit-derived metabolites in a mouse model of inflammatory bowel disease." Molecular nutrition and food research doi: 10.1002/mnfr.201100302.
  10. Morgan AR, Han DY, Thompson JM, Mitchell EA and Ferguson LR (2011) Analysis of MMP2 promoter polymorphisms in childhood obesity. BMC research notes 4: 253.
  11. Morgan AR, Han DY, Lam WJ, Triggs CM, Fraser AG, Barclay M, Gearry RB, Meisner
    S, Stokkers P, Boeckxstaens GE, Ferguson LR. (2011 ) Genetic variations in matrix metalloproteinases may be associated with increased risk of ulcerative colitis. Hum Immunol. 72: 1117-27
  12. Nolan-Clark D, Tapsell LC, Hu R, Han DY and Ferguson LR (2011) Effects of Dairy Products on Crohn's Disease Symptoms Are Influenced by Fat Content and Disease Location but not Lactose Content or Disease Activity Status in a New Zealand Population. J Am Diet Assoc 111: 1165-1172.
  13. Otter, D., M. Cao, et al. (2011). "Identification of urinary biomarkers of colon inflammation in IL10-/- mice using short-column LCMS metabolomics." Journal of Biomedicine and Biotechnology 6: 974-701.
  14. Roy NC, Altermann E, Park ZA and McNabb WC (2011) A comparison of analog and Next-Generation transcriptomic tools for mammalian studies. Briefings in Functional Genomics 10: 135-150.
  15. Wang AH, Lam W-J, Han D-Y, Ding Y, Hu R, Fraser AG, Ferguson LR and Morgan AR (2011) The effect of IL-10 genetic variation and interleukin 10 serum levels on Crohn's disease susceptibility in a New Zealand population. Hum Immunol 72: 431-435.


2010

  1. Barnett MPG, Bermingham EN, McNabb WC, Bassett S, Armstrong KM, Rounce JR, Roy NC (2010). Investigating micronutrients and epigenetic mechanisms in relation to inflammatory bowel disease. Mutation Research 690: 71-80
  2. Barnett, PG, Ferguson LR, (2010) Gene-Diet Interactions in Gut Health, Auckland, New Zealand. Meeting report: Fourth Asia-Pacific Nutrigenomics conference , February 21-25, 2010. Biotechnology Journal 5: 913-918.
  3. Danesi F, Philpott M, Huebner C, Bordoni A, Ferguson LR (2010). Food-derived bioactives as potential regulators of the IL-12/IL-23 pathway implicated in inflammatory bowel diseases. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 690: 139-144.
  4. Dug Yeo H, Fraser AG, Dryland P and Ferguson LR (2010) Environmental factors in the development of chronic inflammation: a case-control study on risk factors for Crohn's disease within New Zealand. Mutation Research -- Fundamental and Molecular Mechanisms of Mutagenesis 690:116-122
  5. Ferguson LR (2010).  Nutrigenomics and inflammatory bowel diseases. Expert Review in Clinical Immunology, 6: 573-583.
  6. Ferguson LR (2010). Chronic inflammation and mutagenesis. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 690: 3-11
  7. Ferguson LR, Hu R, Lam WJ, Munday K, Triggs CM (2010). Tailoring New Zealand foods to match people's genes: opportunities for collaboration. World Review of Nutrition and Dietetics 3: 305-311.
  8. Ferguson LR (2010). Genome-wide association studies and diet. World Review of Nutrition and Dietetics 101: 8-14
  9. Ferguson LR (2010). Interactions between genes and diet in the etiology of colorectal cancer. World Journal of Gastrointestinal Oncology 2: 125-129.
  10. Ferguson LR,  Laing W (2010). Chronic inflammation and human disease. Mutation Research: Fundamental & Molecular Mechanisms, Special issue: 690: 1-2.
  11. Ferguson LR, Tatham AL, Lin Z, Denny WA (2010). Epigenetic regulation of gene expression as an anticancer drug target. Review in Current Cancer Drug Targets: 11: 199-212.
  12. Ferguson LR, Han DY, Fraser AG, Huebner C, Lam WJ, Morgan AR, Duan H, Karunasinghe N (2010). Genetic factors in chronic inflammation: Single nucleotide polymorphisms in the STAT-JAK pathway, susceptibility to DNA damage and Crohn's disease in a New Zealand population. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 690:108-115
  13. Han DY, Fraser AG, Dryland P and Ferguson LR (2010) Environmental factors in the development of chronic inflammation: A case-control study on risk factors for Crohn's disease within New Zealand. Mutat Res-Fundam Mol Mech Mutag 690: 116-122.
  14. Huebner C, Petermann I, Lam WJ, Shelling AN, Ferguson LR (2010). Characterization of single-nucleotide polymorphisms relevant to inflammatory bowel disease in commonly used gastrointestinal cell lines. Inflammatory Bowel Diseases 16: 282-95.
  15. Knoch B, McNabb WC & Roy NC (2010). Influence of polyunsaturated fatty acids on intestinal barrier function during colitis. Agro FOOD Industry High-tech 21: 29-31.
  16. Knoch B, Barnett MPG, Cooney J, McNabb WC, Barraclough D, Laing W, Zhu ST, Park ZA, McLean P, Knowles SO, Roy NC (2010). Molecular characterization of the onset and progression of colitis in inoculated interleukin-10 gene-deficient mice: a role for PPAR. PPAR Research 2010: 621069
  17. Knoch B, Barnett MPG, McNabb WC, Zhu ST, Park ZA, Khan A, Roy NC (2010). Dietary arachidonic acid-mediated effects on colon inflammation using transcriptome analysis. Molecular Nutrition and Food Research 54: S62-S74.
  18. Knoch B, Nones K, Barnett MPG, McNabb WC and Roy NC (2010) Diversity of caecal bacteria is altered in interleukin-10 gene-deficient mice before and after colitis onset and when fed polyunsaturated fatty acids. Microbiology 156: 3306-3316.
  19. Knoch B, Barnett MPG, Cooney J, Barraclough D, Laing W, McNabb WC, Roy NC (2010). Dietary oleic acid as control fatty acid for polyunsaturated fatty acid intervention studies: a transcriptomics and proteomics investigation using interleukin-10 gene-deficient mice. J. Biotechnology 5: 1226-40.
  20. Lin HM, Barnett MP, Roy NC, Joyce NI, Zhu S, Armstrong K, Helsby NA, Ferguson LR, Rowan DD (2010). Metabolomic analysis identifies inflammatory and noninflammatory metabolic effects of genetic modification in a mouse model of Crohn's disease. Journal of Proteome Research 9: 1965-75.
  21. Lin, H.-M., N. A. Helsby, Rowan, D.D. Ferguson L.R.. (2010). "Using metabolomic analysis to understand Inflammatory Bowel Disease." Inflamm. Bowel Disease: 17: 1021-1029.
  22. Morgan AR, Han DY, Huebner C, Lam WJ, Fraser AG, Ferguson LR (2010). PTPN2 but not PTPN22 is associated with Crohn's disease in a New Zealand population. Tissue Antigens, 76: 119-125
  23. Morgan AR, Han DY, Lam WJ, Fraser AG, Ferguson LR (2010). Association analysis of 3p21 with Crohn's disease in a New Zealand population. Human Immunology. 71: 602-609
  24. Rakhshandehroo M, Knoch B, Müller M, Kersten S (2010). Peroxisome proliferator-activated receptor alpha target genes. PPAR Res. 2010;2010. pii: 612089.
  25. Russ AE, Barnett MPG, McNabb WC, Anderson RC, Reynolds GW, Roy NC (2010). Post-weaning effects of milk and milk components on the inflamed intestinal mucosa. Mutation Research 690: 64-70 
  26. Tian H, Maddox IS, Ferguson LR, Shu Q (2010). Evaluation of the cytoprotective effects of bovine lactoferrin against intestinal toxins using cellular model systems. Biometals. 23: 589-592. 
  27. Tian H, Maddox IS, Ferguson LR, Shu Q (2010). Influence of bovine lactoferrin on selected probiotic bacteria and intestinal pathogens. Biometals. 23: 593-596
  28. Triggs CM, Munday K, Hu R, Fraser AG, Gearry RB, Barclay ML, Ferguson LR (2010). Dietary factors in chronic inflammation: Food tolerances and intolerances of a New Zealand Caucasian Crohn's disease population. Mutation Research. 690: 123-138

 

2009

  1. Baker PI, Love DR, Ferguson LR (2009). Role of gut microbiota in Crohn's disease. Expert Review of Gastroenterology and Hepatology 3: 535-46.
  2. Barnett MPG, McNabb WC, Davy M, Zhu ST, Cookson A, Knoch B, Nones K & Roy NC (2009). Changes in colon gene expression associated with increased colon inflammation in interleukin-10 gene-deficient mice inoculated with Enterococcus species. BMC Immunology 11: 39.
  3. Ferguson LR (2009). Epigenetic Variation and Customising Nutritional Intervention. Current Pharmacogenomics and Personalized Medicine 7: 115-124.
  4. Ferguson LR (2009). Nutrigenomics approaches to functional foods (Review). Journal of the American Dietetic Association 109: 452-458.
  5. Ferguson LR (2009). Nutrigenomics: Integrating genomic approaches into nutrition research, In: Patrinos G, Ansorge W ed. Molecular diagnostics, 2nd edition. Oxford, UK, Elsevier Academic Press. Pp. 345-361.
  6. Ferguson LR, Morgan AR, Huebner C, Zhu ST, Hu R (2009). New Zealand research in diet-gene interactions - an overview. Proceedings of the Nutrition Society of Australia 33: 1-1.
  7. Ferguson LR, Han DY, Huebner C, Petermann I, Barclay ML, Gearry RB, McCulloch A, Demmers PS (2009). Tumor necrosis factor receptor superfamily, member 1B (TNFRSF1B) haplotypes increase or decrease the risk of inflammatory bowel diseases in a New Zealand Caucasian population. Gastroenterology Research and Practice: 591704. .
  8. Huebner C, Ferguson LR, Han DY, Philpott M, Barclay ML, Gearry RB, McCulloch A, Demmers PS, Browning BL (2009). Nucleotide-binding oligomerization domain containing 1 (NOD1) haplotypes and single nucleotide polymorphisms modify susceptibility to Inflammatory Bowel Diseases in a New Zealand Caucasian population: a case-control study. BMC Research Notes 2: 52.
  9. Huebner C, Browning BL, Petermann I, Yeo Han D, Philpott M, Barclay M, Gearry R, McCulloch A, Demmers P, Ferguson LR (2009). Genetic analysis of MDR1 and inflammatory bowel disease reveals protective effect of heterozygous variants for ulcerative colitis. Inflammatory Bowel Diseases 15: 1784-1793.
  10. Knoch B, Barnett MPG, Roy NC & McNabb WC (2009). Study of the effects of dietary polyunsaturated fatty acids: Molecular mechanisms involved in intestinal inflammation. International Journal of Fats and Oils 60: 8-21.
  11. Knoch B, Barnett MPG, Zhu ST, Park ZA, Nones K, Dommels YEM, Knowles SO, McNabb WC & Roy NC (2009). Genome-wide analysis of genes involved in dietary eicosapentaenoic acid- and oleic acid-induced modulation in colon inflammation of interleukin 10 gene deficient mice. Journal of Nutrigenetics and Nutrigenomics 2: 9-28.
  12. Lin HM, Edmunds SI, Helsby NA, Ferguson LR, Rowan DD (2009). Nontargeted urinary metabolite profiling of a mouse model of Crohn's disease. Journal of Proteome Research 8: 2045-2057.
  13. Nones K, Dommels YE, Martell S, Butts C, McNabb WC, Park ZA, Zhu ST, Hedderley D, Barnett MPG & Roy NC (2009). The effects of dietary curcumin and rutin on colonic inflammation and gene expression in multidrug resistance gene-deficient (mdr1a-/-) mice, a model of inflammatory bowel diseases. British Journal of Nutrition 101: 169-81.
  14. Nones K, Dommels YEM, Barnett MPG, McNabb WC, Park-Ng ZA, Sheridan S & Roy NC (2009). Multidrug resistance gene deficient mice have an altered caecal microflora that precedes the onset of intestinal inflammation. Journal of Applied Microbiology 107: 557-566.
  15. Petermann I, Huebner C, Browning BL, Gearry RB, Barclay ML, Kennedy M, Roberts R, Shelling AN, Philpott M, Han DY, Ferguson LR (2009). Interactions among genes influencing bacterial recognition increase IBD risk in a population-based New Zealand cohort. Human Immunology 70: 440-446.
  16. Petermann I, Triggs CM, Huebner C, Dug Yeo Han, Gearry RB, Murray L, Barclay ML, Demmers PS, McCulloch A, Ferguson LR (2009). Mushroom intolerance: a novel diet-gene interaction in Crohn's disease, British. Journal of Nutrition 102: 506-508.
  17. Sun-Waterhouse D, Chen J, Chuah C, Wibisono R, Melton LD, Laing W, Ferguson LR, Skinner MA (2009). Kiwifruit-based polyphenols and related antioxidants for functional foods: kiwifruit extract-enhanced gluten-free bread. International Journal of Food Sciences and Nutrition 60 (Suppl 7): 251-64.

2008

  1. Browning BL, Annese V, Barclay ML, Bingham SA, Brand S, Büning C, Castro M, Cucchiara S, Dallapiccola B, Drummond H, Ferguson LR, Ferraris A, Fisher SA, Gearry RB, Glas J, Henckaerts L, Huebner C, Knafelz D, Lakatos L, Lakatos PL, Latiano A, Liu X, Mathew C, Müller-Myhsok B, Newman WG, Nimmo ER, Noble CL, Palmieri O, Parkes M, Petermann I, Rutgeerts P, Satsangi J, Shelling AN, Siminovitch KA, Török HP, Tremelling M, Vermeire S, Valvano MR, Witt H (2008). Gender-stratified analysis of DLG5 R30Q in 4707 Crohn's disease patients and 4973 controls from 12 Caucasian cohorts. Journal of Medical Genetics 45: 36-42.
  2. Browning BL, Browning SR. (2008). Haplotypic analysis of Wellcome Trust Case Control Consortium data. Human Genetics 123: 273-80.
  3. Dryland PA, Love DR, Walker MF, Dommels Y, Butts C, Rowan D, Roy NC, Helsby N, Brian L. Browning BL, Zhu S, Copp BR, Ferguson LR (2008). Allantoin as a biomarker of inflammation in an Inflammatory Bowel Disease mouse model: NMR analysis of urine. The Open Bioactive Compounds Journal, 1: 1-6.
  4. Ferguson LR (2008). Nutrigenomics approaches to functional foods: reducing or enhancing the complexity? Journal American of Dietetics Association 109: 452-458
  5. Ferguson LR, Huebner C, Petermann I, Gearry RB, Barclay ML, Demmers P, McCulloch A, Han DY (2008). Single nucleotide polymorphisms in the promoter of the Tumor necrosis factor-alpha gene affect the risks of developing Inflammatory Bowel Diseases: New Zealand data and a meta-analysis. World Journal of Gastroenterology 14: 4652-4661
  6. Ferguson LR, Browning BL, Huebner C, Petermann I, Shelling AN, Demmers P, McCulloch A, Gearry RB, Barclay ML, Philpott M (2008). Single nucleotide polymorphisms in human Paneth cell defensin A5 may confer susceptibility to inflammatory bowel disease in a New Zealand Caucasian population. Digestive and Liver Disease 40: 723-730.
  7. Ferguson LR, Philpott M, Barnett MPG (2008). Genomic approaches to personalised nutrition. Food-FRENZ 2: 34-35.
  8. Ferguson LR (2008). Dissecting the nutrigenomics, diabetes and gastrointestinal disease interface: From risk assessment to health intervention. OMICS Journal of Integrative Biology: Special Theme Issue on Nutrigenomics 12: 237-244.
  9. Roy NC, Barnett MPG, Bermingham EN, Anderson RC, McCann MJ and McNabb WC (2008). A molecular systems approach to understanding how foods affect gut function and health: how can we use such an approach to develop future smart foods? Food-FRENZ 2: 40-41.
  10. Sutherland J, Miles M, Hedderley D, Li J, Devoy S, Sutton K & Lauren D (2008). In vitro effects of food components on selected probiotic and pathogenic bacteria. International Journal of Food Sciences and Nutrition 60: 717-727

2007

  1. Browning BL, Browning SR. (2007). Efficient multilocus association testing for whole genome association studies using localized haplotype clustering. Genetics and Epidemiology 31: 365-75.
  2. Browning BL, Huebner C, Petermann I, Demmers P, McCulloch A, Gearry R, Barclay M, Shelling AN, Ferguson LR (2007). Association of DLG5 variants with inflammatory bowel disease in the New Zealand Caucasian population and metaanalysis of the DLG5 R30Q variant. Inflammatory Bowel Diseases 13: 1069-76.
  3. Browning BL, Huebner C, Petermann I, Gearry R, Barclay M, Shelling AN, Ferguson LR. (2007). Has toll-like receptor 4 been prematurely rejected as an inflammatory bowel disease gene? Association study combined with meta-analysis shows strong evidence for association. American Journal of Gastroenterology 102: 2504-12.
  4. Browning SR, Browning BL. (2007). Rapid and accurate haplotype phasing and missing-data inference for whole-genome association studies by use of localized haplotype clustering. American Journal of Human Genetics 81: 1084-97.
  5. Dommels YEM, Butts CA, Zhu S, Davy M, Martell S, Hedderley D, Barnett MPG, McNabb WC, Roy NC (2007). Characterization of intestinal inflammation and identification of related gene expression changes in mdr1a-/- mice. Genes & Nutrition 2: 209-223.
  6. Ferguson LR Shelling AN, Browning BL, Huebner C, Petermann I (2007). Genes, diet and inflammatory bowel disease, Mutation Research: Fundamental Molecular Mechanisms and Mutagenesis 622: 70-83.
  7. Ferguson LR, Petermann I, Huebner C, Philpott M, Shelling AN (2007). Uncoupling gene-diet interactions in inflammatory bowel disease, Genes & Nutrition 2: 71-73.
  8. Ferguson LR, Philpott M, Dryland P (2007). Nutrigenomics in the whole-genome scanning era: Crohn's Disease as example. Cellular and Molecular Life Sciences 64: 3105-18.
  9. Ferguson LR, Philpott M. (2007). Cancer prevention by dietary bioactive components that target the immune response. Current Cancer Drug Targets 7: 459-64.
  10. Ferguson LR, Shelling AN, Lauren D, Heyes JA, McNabb W (2007). Nutrigenomics and gut health. Mutation Research: Fundamental Molecular Mechanisms and Mutagenesis 622: 1-6.
  11. Ferguson LR, Barnett MPG, Roy NC & McNabb WC (2007). Influence of nutritional factors on genetic and epigenetic events relevant to chronic diseases. Agro FOOD Industry High-tech 18: 49-51.
  12. Ferguson LR, Shelling AN, Lauren D, McNabb WC (2007). Nutrigenomics and gut health: meeting report from an international conference in Auckland , New Zealand , April 30, May 1-3, 2006. Genes & Nutrition 2: 157-160.
  13. Ghosh D, Skinner MA, Laing WA (2007). Pharmacogenomics and nutrigenomics: synergies and differences. European Journal of Clinical Nutrition 61:67-74.
  14. Huebner C, Petermann I, Browning BL, Shelling AN, Ferguson LR (2007). Triallelic SNPs and genotyping error in genetic epidemiology studies - MDR1 (ABCB1) G2677/T/A as an example. Cancer Epidemiology, Biomarkers & Prevention 16: 1185-92.
  15. Love DR, Lan CC, Dodd A, Shelling AN, McNabb WC, Ferguson LR. (2007). Modelling inflammatory bowel disease: the zebrafish as a way forward. Expert Review Molecular Diagnostics 7: 177-93.
  16. Philpott M, Mackay L, Ferguson LR, Forbes D, Skinner M (2007). Cell culture models in developing nutrigenomics foods for inflammatory bowel disease. Mutation Research: Fundamental Molecular Mechanisms and Mutagenesis 622: 94-102.
  17. Roy NC, Barnett MPG, Knoch B, Dommels Y, McNabb WC (2007). Nutrigenomics applied to an animal model of Inflammatory Bowel Diseases: transcriptomic analysis of the effects of eicosapentaenoic acid- and arachidonic acid-enriched diets. Mutation Research: Fundamental Molecular Mechanisms and Mutagenesis 622: 103-16.
  18. Shelling AN, Ferguson LR (2007). Genetic variation in human disease, and a new role for copy number variants. Mutation Research: Fundamental Molecular Mechanisms and Mutagenesis 622: 33-41.
  19. Sutton K (2007). Considerations for the successful development and launch of personalised nutrigenomic foods. Mutation Research: Fundamental Molecular Mechanisms and Mutagenesis 622: 117-121.

2006

  1. Browning BL (2006). DLG5 variants and susceptibility to inflammatory bowel disease in the Scottish population. Gut 55: 1050-1050.
  2. Browning BL (2006). FLOSS: Flexible ordered subset analysis for linkage mapping of complex traits. Bioinformatics 22: 512-513.
  3. Comeskey DJ, Cooney JM, Rowan DD. (2006). Synthesis of deuterated dihydrochalcones. Journal of Labelled Compounds and Radiopharmaceuticals 49: 479-487.
  4. Ferguson LR (2006). Nutrigenomics and clinical nutrition. Complete Nutrition 6, 13-15.
  5. Ferguson L (2006). Nutrigenomics: integrating genomic approaches into nutrition research. Molecular Diagnosis and Therapy 10: 101-108.
  6. Ghosh D, Skinner M, Ferguson LR (2006). The role of the Therapeutic Goods Administration and the Medicine and Medical Devices Safety Authority in evaluating complementary and alternative medicines in Australia and New Zealand . Toxicology 221: 88-94.

2005

  1. Ferguson L, Philpott M. (2005). New Zealand - fertile ground for functional foods and nutrigenomics. Current Topics in Nutraceutical Research 3, 199-204.
  2. Kaput J, Ordovas JM, Ferguson L, van Ommen B, Rodriguez RL, Allen L, Ames BN, Dawson K, German B, Krauss R, Malyj W, Archer MC, Barnes S, Bartholomew A, Birk R, van Bladeren P, Bradford KJ, Brown K, Caetano R, Castle D, Chadwick R, Clarke S, Clément K, Corella D, Manica da Cruz IB, Daniel H, Duster T, Ebbesson SOE, Elliott R, Fairweather-Tait S, Felton J, Fenech M, Finley JW, Fogg-Johnson N, Gill-Garrison R, Gibney MJ, Gillies PJ, Gustafsson J-A, Hartman JL, He L, Hwang J-K, Jang Y, Joost H, Junien C, Kanter M, Kibbe WA, Koletzko B, Korf BR, Kornman K, Krempin DW, Langin D, Lauren DR, Lee JH, Leveille GA, Lin S-J, Mathers J, Mayne M, McNabb W, Milner JA, Morgan P, Muller M, Nikolsky Y, van der Ouderaa R, Park T, Pensel N, Perez-Jimenez F, Philippe J, Poutanen K, Roberts M, Saris W, Schuster G, Shelling AN, Simopoulos AP, Southon S, Tai ES, Towne B, Trayhurn P, Uauy R, Visek WJ, Warden C, Weiss R, Wiencke J, Winkler J, L. Wolff GL, Zhao- Wilson X, Zucker J-D (2005). The case for strategic international alliances to harness nutritional genomics for public and personal health. British Journal of Nutrition 94, 623-632.

 

 
Printable version
 

Copyright © 2004 Nutrigenomics New Zealand